IPO8
Basic information
Region (hg38): 12:30628988-30695869
Previous symbols: [ "RANBP8" ]
Links
Phenotypes
GenCC
Source:
- VISS syndrome (Strong), mode of inheritance: AR
- VISS syndrome (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| VISS syndrome | AR | Cardiovascular | Among ohther findings, the condition can include increased risk of aneurysms and other cardiovascular anomalies, and awareness may enable surveillance and early interventions | Allergy/Immunology/Infectious; Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Pulmonary | 34010604; 34010605 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (84 variants)
- not_provided (40 variants)
- VISS_syndrome (24 variants)
- IPO8_related_Connective_tissue_disorder (11 variants)
- IPO8-related_aortopathy (8 variants)
- IPO8-related_disorder (6 variants)
- Duane-radial_ray_syndrome (1 variants)
- not_specified (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IPO8 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006390.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 14 | 14 | ||||
| missense | 94 | 101 | ||||
| nonsense | 8 | |||||
| start loss | 0 | |||||
| frameshift | 9 | |||||
| splice donor/acceptor (+/-2bp) | 4 | |||||
| Total | 12 | 11 | 95 | 17 | 1 |
Highest pathogenic variant AF is 0.00000867623
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| IPO8 | protein_coding | protein_coding | ENST00000256079 | 25 | 66999 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.234 | 0.766 | 125717 | 0 | 31 | 125748 | 0.000123 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.12 | 408 | 547 | 0.745 | 0.0000274 | 6855 |
| Missense in Polyphen | 50 | 110.02 | 0.45446 | 1374 | ||
| Synonymous | -0.316 | 195 | 189 | 1.03 | 0.00000940 | 1884 |
| Loss of Function | 5.71 | 15 | 64.5 | 0.232 | 0.00000354 | 729 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000340 | 0.000334 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.0000928 | 0.0000924 |
| European (Non-Finnish) | 0.000177 | 0.000176 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000654 | 0.0000653 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Seems to function in nuclear protein import, either by acting as autonomous nuclear transport receptor or as an adapter- like protein in association with the importin-beta subunit KPNB1. Acting autonomously, is thought to serve itself as receptor for nuclear localization signals (NLS) and to promote translocation of import substrates through the nuclear pore complex (NPC) by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. In vitro mediates the nuclear import of SRP19. {ECO:0000269|PubMed:11682607, ECO:0000269|PubMed:9214382}.;
- Pathway
- Gene expression (Transcription);Transcriptional regulation by small RNAs;Gene Silencing by RNA
(Consensus)
Recessive Scores
- pRec
- 0.175
Intolerance Scores
- loftool
- 0.677
- rvis_EVS
- -0.91
- rvis_percentile_EVS
- 10.07
Haploinsufficiency Scores
- pHI
- 0.264
- hipred
- Y
- hipred_score
- 0.601
- ghis
- 0.670
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.808
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ipo8
- Phenotype
Gene ontology
- Biological process
- protein import into nucleus;signal transduction;regulation of gene silencing by miRNA
- Cellular component
- nuclear envelope;nucleoplasm;cytosol
- Molecular function
- protein binding;Ran GTPase binding;protein transporter activity